News & Events category:
Manchester Royal Infirmary

In a UK first, researchers in Manchester are successfully identifying patients in the early, curable stages of a common liver cancer using a new, innovative test.

A woman in Manchester is the first person in the UK to receive an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints,

Innovative research in Manchester illustrates the potential to dramatically reduce hospitalisations by 58 per cent, improve patient care and save lives.

MFT researchers Dr James Bluett is National Specialty Lead for Musculoskeletal and Orthopaedics and Professor Sandip Mitra is National Setting Lead for Hospitals in NIHR's

MFT Critical Care Consultant, Jonathan Bannard-Smith shares his experiences of mentoring an aspiring Principal Investigator through the NIHR API Scheme.

The first patient has been recruited to a new device study which aims to improve dialysis treatment by preventing side effects for kidney disease patients.

R&I colleagues welcomed James McLaughlin, Chief Executive for Cure Leukaemia, to MFT, as he ran 14 km across Manchester to raise funds for blood cancer research at Manchester Royal Infirmary (MRI).

A special event took place to celebrate 10 years of MFT’s involvement in ‘Enroll-HD’ – a global registry study for Huntington's disease.